|
Volumn 5, Issue 12, 2001, Pages 1109-1115
|
Design of regimens for treating tuberculosis in patients with HIV infection, with particular reference to sub-Saharan Africa
a a a |
Author keywords
HIV; Treatment regimens; Tuberculosis
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIRETROVIRUS AGENT;
CORTICOSTEROID;
COTRIMOXAZOLE;
ISONIAZID;
MULTIVITAMIN;
PROTEINASE INHIBITOR;
QUINOLONE DERIVATIVE;
RIFAMPICIN;
THIOACETAZONE;
TUBERCULOSTATIC AGENT;
AFRICA;
CLINICAL TRIAL;
COMMUNITY CARE;
DISEASE ASSOCIATION;
DRUG BLOOD LEVEL;
DRUG CHOICE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG WITHDRAWAL;
HOSPITAL INFECTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
MEDICAL DECISION MAKING;
MORBIDITY;
PRIORITY JOURNAL;
RECURRENT INFECTION;
REVIEW;
SKIN ALLERGY;
TREATMENT OUTCOME;
TREATMENT PLANNING;
TUBERCULOSIS;
AFRICA SOUTH OF THE SAHARA;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTITUBERCULAR AGENTS;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, BACTERIAL;
DRUG THERAPY, COMBINATION;
GOVERNMENT PROGRAMS;
HUMANS;
ISONIAZID;
RECURRENCE;
RIFAMPIN;
RISK FACTORS;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
TUBERCULOSIS, PULMONARY;
|
EID: 0035674782
PISSN: 10273719
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (10)
|
References (30)
|